Medical Device Industry News

  • Apple Has a Bug to Exterminate from Its HealthKit Apps

    Fanfare for the iOS 8 debut of Apple’s HealthKit apps fizzled this week when the company announced a software bug would delay the apps’ availability for about two weeks when it would be offered as part of a software update.Regardless, the iOS 8 operating system debuted September 17.

  • 4 Medtech Companies Making a Comeback in 2014

    This year is proving to be a pretty good year for many medtech companies. The majority of the largest 40 have seen their stock prices rise by double-digit percentages in 2014, according to a Qmed analysis. Meanwhile, only eight have seen their stock prices decline since January 1.

  • The Worst Performing Medical Device Companies of 2014

    Eight of the largest 40 medical device companies saw their stock prices decline during the first nine months of 2014—with reasons ranging from Drägerwerk AG grappling with the Ukrainian crisis’ effects and health system cost-cutting in the United States, to Getinge AB's continued issues with the FDA.

  • Why St. Jude Medical Might Have a Trancatheter Valve Problem

    When it comes to transcatheter aortic valve replacement (TAVR) technology, St. Jude is less upbeat than Medtronic, Edwards, or Boston Scientific. While those companies proudly announced positive data from their TAVR products at the Transcatheter Cardiovascular Therapeutics event in Washington D.C., St. Jude declared that it was temporarily halting implants of its Portico transcatheter aortic valve replacement (TAVR) devices after it spotted a problem with the devices. 

  • Medtronic Hopes to Expand Cardio Biz

    Medtech giants jockeyed for attention to their coronary catheterization products at the 26th Transcatheter Cardiovascular Therapeutics (TCT) meeting held this week in Washington, D.C., according to a report on and company announcements. Minneapolis-based Medtronic had lots to talk about. The Food and Drug Administration gave 510(k) approval last week to its NC Euphora Noncompliant Balloon Dilatation Catheter for use in heart replacement surgeries. The company received the CE Mark to market the device in Europe in May.

  • Danaher to Pay $2 Billion for Swiss Dental Firm

    Life sciences conglomerate Danaher has announced plans to acquire dental firm Nobel Biocare Holding for $2.1 billion in cash. The deal, assuming it passes regulator muster, could close by the end of this year or early 2015. The move marks the first acquisition for Danaher CEO Thomas Joyce, who assumed his role on last week, on September 9.

  • Allergan Cuts More Jobs as It Fights Hostile Takeover Attempt

    Botox-maker Allergan filed a notice September 3 with California state officials indicating it will lay off 129 employees on October 31. The company previously announced it would lay off about 1500 workers by the end of the year in another move to thwart the hostile takeover from Pershing Square Capital Management, according to a report in the Orange County Business Journal.

  • Smartphone-based ECG Takes India by Storm

    A network of hospitals in India has agreed to use AliveCor Inc.’s smartphone-enabled heart monitor to screen patients across that country for heart arrhythmia and risk of stroke, according to a joint announcement. 

  • Google Aims to Help Parkinson's Patients Eat with New Acquisition

    Google has lengthened its leap into medtech by acquiring Lift Labs, a San Francisco startup that makes a spoon to help prevent patients with movement disorders from spilling their food.

  • Boston Sci Murder Case Suspect Arrested

    Shakopee, MN police on Thursday announced the arrest of Lyle “Ty” Marvin Hoffman, suspected of killing a Boston Scientific executive.